This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of galantamine
ADMED_ACHEI_GALANTAMINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
3209 |
4. Check minimum number of events
Min. number of events
3
|
3209 |
5. Include endpointsNone |
3209 |
6. Filter based on genotype QC (FinnGen only) |
3104 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of galantamine
based on the number of shared cases.
Similar with more cases:
- Use of anticholinesterases
- N06DA Anticholinesterases
- Unspecific neurodegenerative disorder
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3104 | 1516 | 1588 |
| Unadjusted period prevalence (%) | 0.63 | 0.54 | 0.73 |
| Median age at first event (years) | 79.65 | 79.61 | 79.67 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3209
- Matched controls
- 32090
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G30.8
ICD-10 Finland
Other Alzheimer disease
8.0
307.7
547
807
G30.1
ICD-10 Finland
Alzheimer disease with late onset
9.7
307.7
1464
2565
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
9.1
307.7
1057
1644
N06DA04
ATC
galantamine; oral
+∞
307.7
3209
125
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
6.2
307.7
642
1235
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
12.2
307.7
699
719
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
6.5
307.7
726
1374
P20
ICPC
Memory disturbance
7.3
307.7
1881
5211
N06DX01
ATC
memantine; oral
10.4
307.7
1696
3126
SPAT1053
SPAT
Memory test
3.7
285.6
1415
5580
N05AX08
ATC
risperidone; systemic
4.5
275.1
825
2276
N06DA03
ATC
rivastigmine; oral, transdermal
4.8
243.1
637
1569
P70
ICPC
Dementia
5.9
214.9
417
786
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
199.5
826
2805
G30.0
ICD-10 Finland
Alzheimer disease with early onset
10.0
147.6
172
181
G30
ICD-10 Finland
Alzheimer disease
7.2
146.8
225
331
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
8.1
127.7
176
229
F06.7
ICD-10 Finland
Mild cognitive disorder
4.1
107.0
311
809
N06DA02
ATC
donepezil; oral
2.8
103.4
612
2477
N05AH04
ATC
quetiapine; oral
2.7
101.5
660
2802
F03
ICD-10 Finland
Unspecified dementia
3.0
95.3
473
1734
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
5.2
91.4
197
402
A28
ICPC
Limited function/disability NOS
2.2
87.5
1158
6662
SPAT1216
SPAT
Assessment of functional ability
2.2
87.2
966
5177
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
8.3
83.8
112
140
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.9
75.6
394
1475
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
73.5
890
4887
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
6.4
67.7
114
184
F0019, G301,
ICD-10 Finland
5.7
67.0
128
234
SPAT1301
SPAT
No procedures
1.9
63.6
1299
8480
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
63.4
505
2319
SPAT1234
SPAT
Support of social functional capacity
2.6
62.3
388
1586
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
4.4
60.7
159
380
SPAT1254
SPAT
Administration of medicine
2.0
60.1
786
4394
L28
ICPC
Limited function/disability (L)
1.9
58.8
967
5848
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
6.4
55.3
93
150
N06AB10
ATC
escitalopram; oral
2.2
51.7
513
2569
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
50.9
573
3012
N06AX26
ATC
vortioxetine; oral
3.2
50.7
213
701
AXX01, ,
SPAT
3.2
48.3
199
647
N06AX11
ATC
mirtazapine; oral
1.8
47.6
1132
7575
N05BA04
ATC
oxazepam; oral
1.8
44.9
952
6141
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
41.9
570
3188
N02BE01
ATC
paracetamol; systemic, rectal
2.0
39.3
2782
24522
R53
ICD-10 Finland
Malaise and fatigue
1.7
39.2
952
6333
SPAT1304
SPAT
Counselling and guidance related to ageing
1.9
36.7
493
2734
R41.3
ICD-10 Finland
Other amnesia
2.7
36.2
202
776
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
34.9
1304
9615
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
34.3
1016
7072
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.5
34.2
118
343
SPAT1101
SPAT
Orthostatic test
2.2
33.7
296
1400
F0009, G300,
ICD-10 Finland
7.4
30.5
44
60
U04
ICPC
Incontinence urine
2.1
29.6
299
1492
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
7.9
29.4
40
51
AA1AD
NOMESCO Finland
CT of head and brain
1.6
29.0
1125
8272
SPAT1229
SPAT
Assessment of need for aid
1.9
28.9
409
2298
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
27.1
240
1136
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
5.4
26.8
53
100
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
26.4
690
4606
A29
ICPC
General symptom/complaint other
1.7
26.1
504
3103
WYA20
NOMESCO Finland
Home visit
2.8
25.9
134
495
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
25.7
1031
7588
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
25.7
736
5021
XA800
NOMESCO Finland
Neuropsychological investigation
3.3
24.9
95
295
N27
ICPC
Fear of neurological disease other
3.3
24.6
94
292
SPAT1252
SPAT
Overall medication plan or its review
1.9
24.5
334
1850
AA1AD, ,
SPAT
9.4
24.4
29
31
TAB00
NOMESCO Finland
Lumbar puncture
2.8
24.3
122
444
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
24.1
351
1986
SPAT1263
SPAT
Sampling
1.5
23.9
1306
10204
SPAT1360
SPAT
Extensive global examination
2.0
23.7
295
1583
F01.9
ICD-10 Finland
Vascular dementia, unspecified
2.6
23.2
133
518
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
22.6
373
2191
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
22.1
350
2029
N03AG01
ATC
valproic acid; systemic, rectal
2.3
22.0
169
754
130
Kela drug reimbursment
Malignant tumour
0.3
21.6
73
2131
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
21.5
1137
8778
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
21.0
565
3774
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
20.7
423
2635
A04
ICPC
Weakness/tiredness general
1.6
20.7
577
3888
R42
ICD-10 Finland
Dizziness and giddiness
1.5
20.6
893
6618
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
20.1
1024
7823
F05.1
ICD-10 Finland
Delirium superimposed on dementia
3.4
19.6
69
204
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
19.1
1290
10348
C10AA01
ATC
simvastatin; oral
1.4
19.1
1764
14933
A98
ICPC
Health maint/preventive medicine
1.5
18.6
2592
23577
G04BD12
ATC
mirabegron; oral
1.6
18.3
460
3017
R41.0
ICD-10 Finland
Disorientation, unspecified
2.1
18.3
183
909
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
17.8
866
6533
I95.1
ICD-10 Finland
Orthostatic hypotension
1.9
17.7
230
1251
S06.0
ICD-10 Finland
Concussion
1.7
17.3
345
2131
SPAT1260
SPAT
Consultation of another employee
1.5
17.2
567
3950
N05AH03
ATC
olanzapine; systemic
2.3
16.9
131
587
SPAT1310
SPAT
Counselling related to known health issue
1.4
16.6
912
7016
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.8
16.6
238
1337
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.8
16.4
240
1356
SPAT1172
SPAT
Guidance concerning hydration
2.1
15.7
147
712
F009, G309,
ICD-10 Finland
3.6
15.5
50
140
N05AD01
ATC
haloperidol; systemic
2.1
15.4
141
677
Z02.7
ICD-10 Finland
Issue of medical certificate
1.8
15.3
235
1346
F0014, G301,
ICD-10 Finland
5.8
14.9
27
47
G04CA02
ATC
tamsulosin; oral
1.4
14.9
952
7488
N29
ICPC
Neurological sympt/complt other
2.8
14.9
74
269
SPAT1312
SPAT
General health counselling
1.4
14.9
849
6553
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
14.8
361
2343
SPAT1139
SPAT
Nutrition survey
2.1
14.6
146
726
H02AB02
ATC
dexamethasone; systemic
0.4
14.4
89
1994
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
3.4
14.2
50
148
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
14.1
206
1164
N06AB06
ATC
sertraline; oral
1.8
13.8
221
1283
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.6
13.8
345
2254
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
13.8
750
5730
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.2
13.7
116
540
SPAT1167
SPAT
Insertion of urinary catheter
1.9
13.7
171
918
N02AA05
ATC
oxycodone; systemic
1.4
13.6
736
5618
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
5.2
13.4
27
52
J01DB01
ATC
cefalexin; oral
1.4
13.3
2268
20532
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
13.2
319
4759
N06AB04
ATC
citalopram; systemic
1.4
13.1
591
4363
SPAT1307
SPAT
Psychosocial counselling and guidance
2.5
12.9
80
325
F01.2
ICD-10 Finland
Subcortical vascular dementia
3.4
12.9
46
138
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.6
12.8
274
1723
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
5.6
12.4
23
41
S01.0
ICD-10 Finland
Open wound of scalp
1.6
12.3
287
1844
A06AD11
ATC
lactulose; oral
1.4
12.1
696
5352
SPAT1251
SPAT
Organisation of medication
1.8
12.0
172
966
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
11.9
199
1171
F0029, G308,
ICD-10 Finland
4.9
11.7
25
51
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
5.5
11.6
22
40
R55
ICD-10 Finland
Syncope and collapse
1.5
11.6
448
3208
W19
ICD-10 Finland
Unspecified fall
1.5
11.6
340
2302
F00
ICD-10 Finland
Dementia in Alzheimer disease
4.2
11.5
30
72
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
11.1
596
4525
SPAT1262
SPAT
Handing over of treatment supplies
1.4
10.9
570
4304
R1250, ,
SPAT
2.6
10.9
64
254
SPAT1325
SPAT
Vaccination
1.3
10.8
1182
9955
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
4.3
10.8
27
63
N30.0
ICD-10 Finland
Acute cystitis
1.4
10.6
531
3983
C10AA05
ATC
atorvastatin; oral
1.3
10.5
1379
11870
N17
ICPC
Vertigo/dizziness
1.4
10.4
436
3167
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
10.1
542
4110
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
4.3
10.0
25
58
N28
ICPC
Limited function/disability (N)
2.4
10.0
67
283
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
3.8
10.0
30
80
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
10.0
145
818
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
14.6
10.0
16
11
J01CA08
ATC
pivmecillinam; oral
1.3
9.9
1142
9650
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
9.9
215
1355
E0000UV, ,
ATC
1.3
9.8
1091
9177
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.1
9.8
6
399
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.0
9.8
99
496
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
9.6
166
986
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.0
9.6
108
562
JN4BD
NOMESCO Finland
Extensive body CT
0.6
9.5
148
2467
Z75.5
ICD-10 Finland
Holiday relief care
2.4
9.4
63
267
F01
ICD-10 Finland
Vascular dementia
3.6
9.2
30
85
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.7
9.0
151
889
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
8.9
304
2120
IHA10, ,
SPAT
3.5
8.9
30
87
AA1CG, ,
SPAT
3.4
8.8
30
88
SPAT1014
SPAT
Treatment of eyes
2.1
8.7
82
400
G04CB01
ATC
finasteride; oral
1.4
8.7
488
3720
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
8.5
17
658
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
0.1
8.4
*
298
XF606, ,
SPAT
3.5
8.4
28
81
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
8.4
490
3760
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
7.9
8.4
18
23
K08.3
ICD-10 Finland
Retained dental root
1.6
8.2
201
1306
A99
ICPC
Disease/condition unspecnature/site
1.5
8.0
278
1946
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.8
1361
11979
WX402
NOMESCO Finland
General anaesthesia
0.7
7.8
199
2950
SPAT1050
SPAT
Extensive neurological examination
2.0
7.7
80
406
S70.0
ICD-10 Finland
Contusion of hip
1.6
7.7
155
962
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.7
7.6
397
5186
Z04.3
ICD-10 Finland
Examination and observation following other accident
2.3
7.6
56
248
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
7.6
1193
10371
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
11.9
7.6
13
11
A04AA02
ATC
granisetron; systemic, transdermal
0.4
7.5
39
936
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.6
7.5
104
1783
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
2.1
7.4
71
350
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.3
7.4
20
650
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
7.3
211
1426
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
7.2
1031
8859
Z28
ICPC
Limited function/disability (Z)
3.0
7.2
30
100
J30.0
ICD-10 Finland
Vasomotor rhinitis
2.1
7.1
66
322
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
7.1
336
2490
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.0
7.0
*
210
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.7
7.0
352
4630
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
7.0
1585
14269
C03DA01
ATC
spironolactone; oral
0.7
6.9
272
3724
SPAT1284
SPAT
Extensive health certificate
2.0
6.7
65
322
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.7
6.6
223
3136
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.8
6.6
90
501
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.6
1080
9398
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
6.5
21
623
R18
ICD-10 Finland
Ascites
0.2
6.5
8
345
K90
ICPC
Stroke/cerebrovascular accident
1.7
6.5
119
722
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
6.3
*
213
A04AA01
ATC
ondansetron; systemic, rectal
0.6
6.2
76
1348
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.5
6.2
54
1063
SPAT1244
SPAT
Occupational therapy
2.5
6.2
37
150
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
6.2
115
701
KED22
NOMESCO Finland
Transurethral resection of prostate
1.4
6.2
237
1694
A01
ICPC
Pain general/multiple sites
1.4
6.2
264
1924
R32
ICD-10 Finland
Unspecified urinary incontinence
1.7
6.1
100
588
R5110, ,
SPAT
1.4
6.1
216
1522
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1302
7370
2.29
107.20
1.9
1.8
1227.49
1165.51
nmol/l
1.60
976
5421
130
157
8.59
100.13
1.1
1.0
395.39
324.93
ng/l
1.41
96
87
130
158
8.53
99.61
1.1
1.0
54.31
46.32
ng/l
0.74
94
86
130
158
8.53
99.61
1.1
1.0
589.40
632.64
ng/l
0.49
96
86
1323
7752
2.20
97.88
1.6
1.6
21.74
19.97
nmol/l
1.96
1079
6495
1850
12669
2.09
87.62
2.3
2.2
94.06
92.47
pmol/l
0.69
964
6429
1520
10465
1.86
62.69
2.1
2.2
78.90
80.90
nmol/l
1.96
1262
8890
987
6104
1.89
55.49
2.4
3.1
2.45
2.47
mmol/l
7.00
876
5247
1418
9859
1.79
53.99
2.3
3.2
2.36
2.35
mmol/l
1.81
1196
8322
1041
6760
1.80
48.73
1.9
1.8
474.78
8240138.17
pmol/l
1.78
799
5340
1729
13191
1.67
43.49
4.3
5.6
1.22
1.21
mmol/l
10.96
1511
11802
2450
20808
1.75
38.41
5.1
5.0
2.09
2.10
mu/l
0.08
2143
18265
1844
14656
1.61
36.49
4.4
6.4
1.22
1.21
mmol/l
8.67
1507
12282
142
459
3.19
34.75
1.2
1.3
494.00
570.60
mg/l
1.26
133
433
2156
17979
1.61
33.28
6.1
5.8
3671.66
2981.53
e6/l
0.23
67
362
126
390
3.32
33.10
1.2
1.3
3.76
33.28
e6/l
1.30
92
319
126
391
3.31
32.97
1.3
1.4
421.44
865.02
e6/l
0.60
95
334
1193
8759
1.58
31.62
2.3
2.1
223.09
226.01
u/l
0.04
1111
8102
832
5642
1.64
30.50
5.4
5.2
1.02
1.02
kg/l
1.61
110
965
1506
11788
1.52
29.11
4.4
4.6
63.27
67.58
ng/l
0.12
1241
9494
2027
17066
1.51
26.48
3.9
3.9
15.31
15.30
pmol/l
0.09
1746
14847
2571
22919
1.61
24.91
17.0
19.6
28.09
28.40
mg/l
0.16
2165
19354
937
6806
1.53
24.64
5.4
5.0
0.00
0.00
estimate
-0.00
201
2096
1565
12698
1.45
23.29
3.1
4.3
35.10
33.98
g/l
14.58
1395
11545
2661
24031
1.63
23.20
21.6
23.8
139.72
139.40
mmol/l
6.43
2562
23280
2661
24053
1.62
22.86
21.6
24.0
4.00
4.02
mmol/l
1.83
2556
23261
2668
24184
1.61
22.06
25.4
28.8
38.74
38.21
%
3.98
2457
21852
2668
24187
1.61
22.01
25.7
28.7
232.38
236.78
e9/l
2.91
2565
23289
2668
24188
1.61
21.99
25.8
28.7
4.28
4.28
e12/l
0.02
2553
23174
2668
24191
1.61
21.95
25.9
28.9
129.91
129.14
g/l
1.95
2587
23592
2668
24192
1.61
21.93
25.7
28.7
7.14
7.10
e9/l
0.24
2552
23173
536
3588
1.59
19.67
9.4
9.4
—
—
—
0
0
1202
9555
1.41
18.62
2.3
2.2
—
—
—
0
0
2589
23560
1.51
18.36
20.4
23.3
84.44
86.85
umol/l
3.99
2584
23552
1484
12297
1.38
17.69
4.8
4.6
0.00
0.00
estimate
0.11
247
2490
1489
12401
1.37
16.93
4.8
4.6
0.00
0.00
estimate
-0.00
218
2219
1158
9328
1.38
15.89
5.1
5.1
—
—
—
0
0
1458
12222
1.35
15.36
5.7
6.2
0.00
0.00
estimate
-0.00
228
2211
2017
17771
1.36
15.32
3.8
4.3
14.64
16.26
mm/h
4.18
1766
15981
746
5630
1.42
14.84
1.7
1.9
—
—
—
0
0
2557
23492
1.44
14.67
9.8
11.3
22.32
22.89
u/l
0.50
2377
22227
1825
15957
1.33
13.87
4.0
4.7
7.02
6.97
mmol/l
0.39
1740
15018
234
1398
1.73
13.22
2.0
2.0
—
—
—
0
0
2278
20675
1.35
12.90
17.0
19.1
67.47
66.55
ml/min/173m2
1.49
1848
17178
216
1281
1.74
12.53
1.9
1.9
—
—
—
0
0
2383
21829
1.36
12.34
5.3
5.3
6.18
6.16
mmol/l
0.17
2015
18911
1682
14796
1.29
11.01
19.9
22.1
1.37
1.44
inr
1.98
477
4016
2132
19351
1.30
10.89
5.2
7.3
78.62
82.87
u/l
2.68
1922
17910
2299
21124
1.31
10.47
6.9
6.9
42.17
41.68
mmol/mol
1.39
1985
18779
432
3172
1.42
9.67
2.5
2.5
4.57
6.14
ug/l
2.20
336
2589
64
282
2.30
8.76
2.9
3.3
319.82
331.93
umol/l
0.30
51
233
2328
21676
1.27
8.10
5.3
5.4
2.40
2.45
mmol/l
2.02
2009
19015
1406
12404
1.24
7.90
2.9
3.1
49.55
56.98
u/l
2.16
1217
10968
1048
8979
1.25
7.62
5.1
5.8
2.71
4.87
ug/l
3.69
907
7823
2152
19927
1.24
7.47
4.2
4.2
1.19
1.24
mmol/l
3.40
1820
17138
2244
20877
1.25
7.46
4.8
4.7
4.27
4.32
mmol/l
1.38
1947
18364
279
1985
1.44
7.40
1.5
1.5
—
—
—
0
0
2206
20605
1.23
6.47
4.8
4.7
1.46
1.45
mmol/l
0.73
1895
17954
409
3171
1.33
6.45
4.9
4.8
35.59
34.45
%
1.06
251
1974
42
910
0.45
6.32
3.3
3.6
1.78
1.71
mmol/l
0.20
42
897
236
1684
1.43
6.19
2.7
2.9
0.60
0.33
e6/l
0.88
231
1657
245
3348
0.71
6.17
2.7
3.7
29.36
21.97
ug/l
0.12
201
2798
84
1417
0.58
5.73
3.4
4.2
0.87
0.87
%
0.03
76
1337
42
869
0.48
5.60
3.3
3.6
9.30
7.95
mmol/l
1.13
42
855
87
1425
0.60
5.31
3.2
4.2
1.83
1.56
%
0.52
80
1345
168
1171
1.46
5.04
1.6
1.5
1.66
1.67
%
0.01
136
931
54
283
1.92
4.87
1.6
1.5
—
—
—
0
0
743
6404
1.21
4.72
2.8
2.8
5.68
5.10
e6/l
0.68
675
5746
290
3689
0.76
4.52
2.7
3.5
238.04
251.76
u/l
1.13
268
3404
158
1118
1.43
4.41
1.9
2.1
447.73
788.29
ug/l
0.80
148
1054
66
1099
0.59
4.35
2.0
2.8
86.31
4780.38
u/ml
1.14
51
931
25
566
0.44
4.33
2.4
2.5
107.24
105.46
mmol/l
0.44
25
561
25
566
0.44
4.33
2.4
2.5
4.08
4.12
mmol/l
0.21
25
561
208
2753
0.74
4.30
3.5
5.3
9.92
12.26
mmol/l
5.49
192
2553
278
2175
1.30
4.14
1.6
1.8
—
—
—
0
0
35
167
2.11
4.13
1.1
1.1
—
2.22
—
0
5
71
1137
0.62
4.02
3.0
2.6
—
—
—
0
0
23
93
2.48
3.96
1.4
1.3
—
—
—
0
0
1101
9959
1.16
3.83
4.2
4.1
120.22
142.74
e6/l
0.33
842
7402
177
2350
0.74
3.75
2.0
2.3
32.56
36.00
u/l
0.87
146
1956
123
1718
0.70
3.59
1.3
1.2
—
—
—
0
0
986
8883
1.16
3.57
3.7
3.6
61.76
97.41
e6/l
1.15
801
6986
28
130
2.16
3.57
1.0
1.1
—
—
—
0
0
462
5430
0.83
3.55
1.6
1.6
1.10
1.26
mmol/l
10.16
361
4412
37
194
1.92
3.43
1.3
1.3
—
—
—
0
0
812
7235
1.16
3.38
4.6
5.0
21.74
22.45
%
0.67
443
3977
29
140
2.08
3.37
1.6
1.7
108.86
93.46
umol/l
0.65
29
140
16
384
0.41
3.29
1.9
1.2
—
—
—
0
0
126
1725
0.72
3.28
1.5
1.6
1.69
1.53
g/l
0.98
102
1450
251
3120
0.79
3.27
1.2
1.3
33.36
42.38
iu/ml
0.59
76
962
1181
10831
1.14
3.26
2.9
3.4
1822.31
2201.12
ng/l
2.30
995
9463
460
3918
1.20
3.26
1.6
1.8
—
—
—
0
0
232
2905
0.78
3.22
1.3
1.2
19.32
16.70
u/ml
0.12
64
928
461
3941
1.20
3.14
1.6
1.8
—
—
—
0
0
5
184
0.27
3.09
1.4
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
89
1275
0.69
3.04
1.7
2.5
0.39
0.35
u/ml
0.30
46
757
370
4372
0.83
3.00
2.0
2.5
21.15
20.59
%
0.33
299
3625
593
6720
0.86
2.95
2.3
2.9
8211.26
8190.17
umol/l
0.00
457
5559
36
201
1.80
2.81
2.7
2.4
—
—
—
0
0
65
429
1.53
2.70
12.6
7.3
9.04
7.36
mmol/l
1.20
45
352
397
4602
0.84
2.60
2.0
2.4
2.27
2.25
g/l
0.31
344
4180
901
8219
1.13
2.60
2.2
2.4
62.40
69.45
u/l
0.28
807
7484
149
1149
1.31
2.57
1.3
1.2
—
—
—
0
0
11
36
3.06
2.56
5.2
2.6
0.82
0.53
u/field
0.34
11
36
117
876
1.35
2.48
2.0
3.2
24.78
25.08
mmol/l
0.33
111
853
59
391
1.52
2.43
1.5
1.6
—
—
—
0
0
0
65
0.00
2.41
0.0
1.2
—
—
—
0
0
18
362
0.49
2.40
5.0
3.5
—
—
—
0
0
43
676
0.63
2.38
1.2
1.5
—
—
—
0
0
268
3189
0.83
2.36
2.3
3.3
5.99
5.81
kpa
1.71
256
3079
10
33
3.04
2.35
1.0
1.2
—
—
—
0
0
29
497
0.58
2.29
1.2
1.2
17.77
44.59
u/l
3.09
22
428
906
8328
1.12
2.27
2.2
2.4
2.98
3.21
mg/l
2.28
733
6999
575
6408
0.87
2.23
3.0
3.9
80.91
80.89
%
0.00
565
6228
87
1180
0.73
2.23
1.8
2.9
45.66
110.90
mg/l
0.77
64
972
140
1094
1.29
2.23
3.3
3.2
0.78
0.84
nmol/l
1.04
104
820
87
1178
0.73
2.21
1.8
2.9
45.75
64.16
mg/l
0.42
65
975
269
3170
0.83
2.15
2.2
3.3
2.14
2.05
mmol/l
0.15
226
2622
56
812
0.68
2.13
1.3
1.6
—
—
—
0
0
9
31
2.91
2.07
1.0
1.2
—
—
—
0
0
18
89
2.03
2.05
2.4
2.1
54.76
48.00
umol/l
0.37
13
71
28
163
1.72
1.98
2.0
2.1
13.76
24.99
umol/l
—
5
19
25
426
0.58
1.97
1.2
1.4
—
—
—
0
0
441
4953
0.87
1.92
2.0
2.4
11.65
11.37
umol/l
0.36
385
4514
238
2015
1.20
1.88
2.6
3.6
5.06
5.18
kpa
1.66
211
1854
48
695
0.69
1.85
3.8
5.5
104.12
104.84
mmol/l
0.46
42
622
342
3900
0.86
1.85
3.0
4.6
0.99
1.04
mmol/l
4.26
311
3507
242
2827
0.84
1.78
1.6
2.4
67.11
65.62
g/l
2.49
203
2468
122
1526
0.79
1.78
2.6
2.7
11.84
10.78
g/l
0.96
107
1351
8
177
0.45
1.69
1.3
1.4
—
—
—
0
0
8
177
0.45
1.69
1.3
1.4
—
—
—
0
0
228
2662
0.85
1.68
2.1
2.9
4.38
4.33
kpa
0.09
220
2558
43
292
1.48
1.67
1.8
1.6
22.89
28.48
u/ml
—
9
67
40
582
0.68
1.62
1.2
1.5
33.14
29.76
g/l
1.24
34
520
106
1328
0.79
1.60
1.3
2.3
3.85
3.68
g/l
0.90
81
1154
107
1333
0.80
1.55
1.3
2.3
7.58
7.59
g/l
0.02
81
1156
107
1330
0.80
1.52
1.3
2.3
—
—
—
0
0
22
357
0.61
1.50
1.2
1.4
—
—
—
0
0
101
1260
0.80
1.49
1.3
2.3
10.43
10.40
g/l
0.02
75
1073
40
569
0.70
1.46
1.2
1.6
—
—
—
0
0
408
4517
0.89
1.44
1.9
2.6
0.81
0.81
mmol/l
0.18
357
4098
25
386
0.64
1.39
1.2
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
111
1.72
1.39
1.1
1.1
—
—
—
0
0
504
4614
1.11
1.35
1.7
1.8
29.52
30.19
s
1.62
490
4432
46
627
0.73
1.33
1.2
1.4
—
—
—
0
0
16
90
1.78
1.33
1.1
1.2
—
59.21
%
—
0
14
41
566
0.72
1.29
1.6
1.5
0.06
15.98
iu/ml
0.89
11
155
22
341
0.64
1.27
1.2
1.4
—
—
—
0
0
67
858
0.78
1.26
1.5
1.2
301.03
197.93
u/ml
0.45
56
768
43
586
0.73
1.26
2.2
3.0
67.22
1036.90
u/ml
1.30
37
528
219
1914
1.15
1.25
2.6
3.6
1.81
2.15
mmol/l
0.59
140
1374
8
160
0.50
1.24
2.4
3.6
—
—
—
0
0
17
277
0.61
1.22
1.8
1.2
—
20.45
—
0
5
308
3428
0.89
1.22
2.5
3.2
197.46
285.39
ng/l
5.52
278
3126
16
93
1.72
1.21
1.1
1.0
—
—
—
0
0
34
476
0.71
1.18
1.1
1.2
7.40
3.82
u/ml
—
5
48
9
167
0.54
1.18
1.1
1.2
—
—
—
0
0
70
881
0.79
1.17
1.4
2.3
0.00
0.00
g/l
-0.00
58
799
0
34
0.00
1.16
0.0
1.3
—
—
—
0
0
178
2046
0.86
1.15
2.1
3.1
130.79
125.39
g/l
2.98
170
1999
282
2526
1.13
1.14
2.8
3.5
1.24
1.22
mmol/l
2.96
225
2172
12
65
1.85
1.13
1.0
1.1
—
—
—
0
0
35
483
0.72
1.13
1.1
1.2
4.57
6.08
u/ml
—
7
83
16
258
0.62
1.12
1.0
1.4
—
—
—
0
0
16
258
0.62
1.12
1.0
1.4
—
—
—
0
0
16
97
1.65
1.06
1.1
1.1
—
—
—
0
0
21
314
0.67
1.06
1.1
1.1
—
—
—
0
0
221
1960
1.14
1.06
2.7
2.9
57.70
55.74
ml/min/173m2
0.51
99
911
18
277
0.65
1.04
1.7
1.3
—
0.31
nmol/l
—
0
19
11
60
1.84
1.02
1.0
1.1
—
—
—
0
0
9
47
1.92
1.02
1.0
1.0
—
—
—
0
0
135
1160
1.17
1.01
2.3
2.5
23.40
26.58
au/ml
—
5
40
9
49
1.84
0.98
2.1
1.4
11.28
9.64
ug/l
—
9
49
140
1615
0.86
0.98
3.4
7.2
24.08
24.42
mmol/l
0.76
129
1521
1068
11143
0.94
0.98
4.0
5.4
2.74
2.79
%
0.31
960
10193
13
212
0.61
0.98
1.0
1.1
—
—
—
0
0
0
30
0.00
0.97
0.0
14.2
—
5.41
—
0
30
46
591
0.78
0.95
2.3
2.5
1.58
1.84
mg/l
1.84
39
504
91
760
1.20
0.95
2.0
2.9
7.79
7.66
kpa
0.40
86
736
30
410
0.73
0.95
1.2
1.2
—
—
—
0
0
1071
11161
0.94
0.94
4.0
5.4
59.34
59.81
%
0.56
965
10243
27
374
0.72
0.93
1.1
1.1
—
—
—
0
0
535
5009
1.08
0.92
3.1
3.4
0.82
0.89
ug/l
0.55
419
3685
34
453
0.75
0.92
2.1
3.5
57.97
60.37
%
0.35
34
453
10
55
1.82
0.92
1.4
1.4
78.69
111.64
ng/l
—
10
55
53
663
0.80
0.89
1.2
1.4
—
—
—
0
0
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
104
1216
0.85
0.88
1.3
2.3
2.92
3.06
g/l
0.78
78
1041
8
42
1.91
0.88
1.0
1.2
—
—
—
0
0
69
837
0.82
0.88
1.7
1.6
68.57
150.23
titre
—
7
43
846
8066
1.07
0.88
3.6
3.5
0.54
0.55
e6/l
0.03
676
6344
343
3718
0.91
0.87
3.4
5.6
11.73
11.63
kpa
0.12
320
3484
19
276
0.69
0.86
1.7
1.3
0.58
0.71
nmol/l
1.17
19
254
11
64
1.72
0.86
1.0
1.1
—
—
—
0
0
11
180
0.61
0.86
1.0
1.1
—
—
—
0
0
15
228
0.66
0.85
1.1
1.2
—
—
—
0
0
1095
11374
0.94
0.85
4.2
5.7
25.56
24.77
%
1.26
988
10432
40
513
0.78
0.84
1.3
1.5
1707.32
1708.27
e6/l
0.00
28
380
36
468
0.77
0.84
1.3
1.4
108261.90
60208.04
e6/l
0.43
21
288
21
297
0.71
0.83
1.2
1.3
12.29
13.15
u/l
0.10
21
271
234
2579
0.90
0.83
1.7
1.9
0.20
0.19
g/l
0.44
214
2340
1048
10076
1.06
0.83
2.4
2.9
134.16
152.61
ug/l
1.62
899
8933
24
331
0.72
0.83
1.5
1.5
—
—
—
0
0
344
3718
0.92
0.82
3.4
5.6
5.06
5.05
kpa
0.05
323
3490
30
399
0.75
0.82
1.3
1.5
—
—
—
0
0
157
1769
0.88
0.82
1.3
1.3
—
—
—
0
0
29
387
0.75
0.81
1.4
1.8
—
—
—
0
0
84
709
1.19
0.81
1.8
2.2
205.05
80.15
ug/min
0.57
39
402
1887
18453
1.05
0.79
19.1
23.1
16.35
15.61
%
4.11
1844
18010
10
58
1.73
0.79
1.0
1.0
—
—
—
0
0
39
303
1.29
0.79
1.5
1.2
266.96
273.92
mosm/kgh2o
1.15
27
205
159
1785
0.89
0.79
2.3
3.3
25.10
25.11
mmol/l
0.01
151
1732
16
235
0.68
0.79
1.9
2.2
763.10
610.95
ml
—
10
134
25
339
0.74
0.78
1.2
1.4
—
—
—
0
0
642
6090
1.07
0.78
4.0
4.4
233.83
457.54
ng/l
0.79
551
5489
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
38
485
0.78
0.78
1.3
1.5
—
—
—
0
0
95
1103
0.86
0.77
1.5
2.4
0.80
1.17
g/l
0.40
70
905
74
876
0.84
0.76
1.5
1.6
—
—
—
0
0
76
897
0.84
0.75
1.4
2.3
0.00
0.00
g/l
-0.00
60
801
254
2768
0.91
0.74
1.9
2.4
9.62
10.27
umol/l
0.15
220
2381
5
24
2.08
0.74
1.2
1.0
—
—
—
0
0
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
7
39
1.80
0.72
1.3
1.1
—
—
—
0
0
31
401
0.77
0.72
1.0
1.4
—
—
—
0
0
31
401
0.77
0.72
1.0
1.4
—
—
—
0
0
22
159
1.39
0.72
1.4
1.3
—
—
—
0
0
22
159
1.39
0.72
1.4
1.3
—
—
—
0
0
14
93
1.51
0.69
1.2
1.2
6.42
6.37
mmol/l
0.04
14
88
76
888
0.85
0.69
1.2
1.1
98.34
117.47
iu/ml
0.10
21
284
10
61
1.64
0.68
1.0
1.5
—
—
—
0
0
7
43
1.63
0.66
2.7
2.4
—
—
—
0
0
13
86
1.51
0.66
1.8
1.4
130.29
101.13
umol/l
—
7
55
82
947
0.86
0.65
1.3
2.3
0.00
0.07
g/l
2.05
65
846
7
44
1.59
0.65
2.4
2.3
—
—
—
0
0
129
1441
0.89
0.63
1.5
1.8
2.57
2.40
ug/l
0.07
94
1212
13
87
1.50
0.63
2.9
2.8
30.63
28.49
umol/l
—
8
57
8
51
1.57
0.60
1.5
1.6
72.13
215.22
nmol/24h
—
8
51
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
22
0.00
0.59
0.0
1.2
—
3790.21
—
0
14
290
2707
1.08
0.59
2.7
5.3
1.50
1.44
mmol/l
0.39
278
2608
492
4678
1.06
0.58
3.3
3.2
2.74
2.47
e6/l
0.30
300
2663
222
2052
1.09
0.58
2.0
2.0
401.67
389.07
nmol/l
0.43
188
1824
6
35
1.72
0.57
1.5
1.1
—
—
—
0
0
494
5186
0.94
0.57
1.5
1.6
1.57
1.61
mg/l
0.07
375
4073
28
353
0.79
0.57
1.1
1.1
—
—
—
0
0
91
1030
0.88
0.57
1.4
2.2
37.65
36.53
g/l
1.30
65
852
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
10
149
0.67
0.56
1.2
1.2
81.80
96.82
u/l
—
10
126
27
341
0.79
0.56
2.4
2.3
6.65
2.14
u/field
2.06
20
94
69
598
1.16
0.55
1.2
1.3
—
—
—
0
0
417
3957
1.06
0.54
1.3
1.2
2.42
1.41
u/ml
0.70
112
949
29
361
0.80
0.54
1.2
1.7
19.00
25.45
ug/l
0.54
29
353
9
61
1.48
0.53
1.0
1.1
—
—
—
0
0
258
2412
1.08
0.52
1.6
1.6
—
—
—
0
0
14
192
0.73
0.52
3.1
3.8
—
—
—
0
0
17
225
0.75
0.50
1.6
1.7
57.29
50.80
nmol/l
0.34
17
208
7
109
0.64
0.48
1.0
1.2
—
—
—
0
0
7
109
0.64
0.48
1.0
1.2
—
—
—
0
0
7
110
0.64
0.48
1.0
1.2
—
—
—
0
0
7
110
0.64
0.48
1.0
1.2
—
—
—
0
0
7
110
0.64
0.48
1.0
1.2
—
—
—
0
0
324
3423
0.94
0.48
1.3
1.5
2.72
2.79
g/l
0.18
147
1837
14
189
0.74
0.48
1.3
1.4
—
—
—
0
0
41
345
1.19
0.47
1.1
1.3
—
—
—
0
0
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
16
121
1.32
0.44
1.3
1.3
—
—
—
0
0
10
140
0.71
0.43
1.2
1.2
30.90
25.50
u/l
—
10
115
20
251
0.80
0.42
1.1
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
400
4177
0.95
0.41
1.9
2.3
1.71
1.79
%
0.85
331
3592
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
46
530
0.87
0.41
1.1
1.3
—
101.54
—
0
13
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
4.9
—
—
—
0
0
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
11
149
0.74
0.40
1.1
1.3
—
—
—
0
0
40
343
1.17
0.39
1.1
1.3
—
—
—
0
0
40
343
1.17
0.39
1.1
1.3
—
—
—
0
0
12
160
0.75
0.39
2.3
1.9
153.58
210.60
pmol/l
1.65
12
149
211
1986
1.07
0.39
1.7
1.8
202.30
164.38
ug/g
0.58
154
1535
356
3722
0.95
0.39
3.3
5.6
1.27
1.22
mmol/l
0.09
264
2855
76
842
0.90
0.38
1.4
1.7
34.99
38.33
u/l
0.72
62
691
40
345
1.16
0.37
1.1
1.3
—
—
—
0
0
40
345
1.16
0.37
1.1
1.3
—
—
—
0
0
39
338
1.16
0.35
1.1
1.3
—
—
—
0
0
22
266
0.83
0.35
1.4
1.5
—
—
—
0
0
6
43
1.40
0.35
1.0
1.2
93.47
152.12
pmol/l
—
6
43
42
479
0.88
0.34
1.3
2.3
215.25
214.72
%
0.01
36
456
265
2525
1.05
0.34
2.7
3.3
83.26
98.27
ng/l
1.87
211
2054
11
82
1.34
0.34
1.5
1.9
1.23
1.11
mmol/l
0.05
11
72
6
89
0.67
0.33
1.2
1.2
—
—
—
0
0
27
317
0.85
0.32
2.3
2.8
—
—
—
0
0
27
317
0.85
0.32
1.7
1.5
1.20
2.96
mg/l
2.98
20
260
15
187
0.80
0.32
1.5
1.7
—
—
—
0
0
15
119
1.26
0.31
1.8
2.2
—
—
—
0
0
15
119
1.26
0.31
1.8
2.2
—
—
—
0
0
71
779
0.91
0.31
2.3
2.3
129.36
124.74
g/l
0.93
58
571
49
437
1.12
0.31
1.9
2.3
33.89
24.73
mg/l
0.49
19
92
1406
13853
1.03
0.31
3.7
5.6
12.92
12.53
umol/l
0.38
1293
13023
12
153
0.78
0.30
1.3
1.5
10.86
6.37
u/l
—
7
123
126
1179
1.07
0.30
3.1
4.0
24.96
24.93
mmol/l
0.03
103
1040
28
325
0.86
0.30
1.3
1.4
—
—
—
0
0
48
536
0.89
0.30
1.8
1.9
1.83
1.73
mmol/l
0.29
48
524
20
239
0.84
0.29
1.3
1.4
20.10
24.48
%
0.32
13
150
77
708
1.09
0.28
3.1
4.0
26.74
30.17
mg/l
0.51
58
483
11
140
0.78
0.28
1.2
1.9
—
—
—
0
0
10
129
0.77
0.28
1.9
2.2
—
—
—
0
0
14
113
1.24
0.26
1.1
1.0
—
—
—
0
0
83
770
1.08
0.26
1.0
1.1
—
—
—
0
0
5
74
0.68
0.26
1.0
1.1
—
—
—
0
0
798
8138
0.97
0.26
3.0
3.1
221.14
343.59
mg/l
0.48
526
5173
829
8133
1.03
0.25
2.9
3.1
7.09
6.59
mmol/l
2.68
643
6539
20
234
0.85
0.24
1.1
1.1
290.00
325.20
u/ml
—
10
120
1143
11596
0.98
0.24
2.2
2.8
—
—
—
0
0
626
6398
0.97
0.24
2.1
2.5
—
—
—
0
0
6
84
0.71
0.24
1.0
1.0
—
—
—
0
0
52
567
0.92
0.23
1.3
1.2
—
—
—
0
0
661
6744
0.97
0.23
2.3
2.9
32.43
36.34
u/l
1.26
609
6310
27
306
0.88
0.23
1.3
1.4
75.35
66.23
%
1.11
20
201
45
494
0.91
0.22
2.8
4.2
1.84
1.62
%
0.08
37
418
87
816
1.07
0.22
1.2
1.4
—
—
—
0
0
87
816
1.07
0.22
1.2
1.4
—
—
—
0
0
56
516
1.09
0.22
1.8
2.1
23.88
31.50
umol/l
2.40
43
447
57
526
1.09
0.21
1.6
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
0.47
—
0
6
149
1556
0.96
0.20
1.8
2.4
0.67
0.65
%
0.33
149
1548
20
229
0.87
0.20
1.1
1.4
—
—
—
0
0
20
229
0.87
0.20
1.1
1.4
—
—
—
0
0
20
229
0.87
0.20
1.1
1.4
—
—
—
0
0
15
176
0.85
0.20
1.2
1.2
—
4.71
—
0
7
83
783
1.06
0.19
1.1
1.2
—
—
—
0
0
75
706
1.06
0.18
1.1
1.2
—
—
—
0
0
67
714
0.94
0.18
2.2
2.6
16.90
15.53
%
2.06
36
366
69
733
0.94
0.17
1.2
1.3
—
—
—
0
0
153
1590
0.96
0.17
1.8
2.4
1.15
1.09
%
0.37
153
1582
507
4974
1.02
0.17
3.1
3.0
1.40
1.38
e6/l
0.04
310
2935
291
2985
0.97
0.16
3.6
6.2
121.46
118.57
g/l
1.64
283
2896
14
162
0.86
0.16
1.3
1.4
—
—
—
0
0
14
162
0.86
0.16
1.3
1.4
—
—
—
0
0
28
254
1.10
0.16
1.2
1.2
16668.47
217151.20
e6/l
2.88
19
172
11
130
0.85
0.16
1.1
1.0
—
—
—
0
0
197
1911
1.03
0.15
3.9
7.0
92.82
93.67
%
0.93
197
1898
220
2140
1.03
0.15
4.6
5.7
24.43
24.48
mmol/l
0.06
208
2031
10
84
1.19
0.14
1.2
1.2
—
—
—
0
0
29
314
0.92
0.12
2.5
3.9
63.19
56.35
%
0.75
21
255
16
142
1.13
0.12
1.0
1.2
—
—
—
0
0
327
3330
0.98
0.12
3.4
5.8
95.02
95.15
%
0.10
307
3180
73
700
1.04
0.11
1.1
1.2
—
—
—
0
0
27
250
1.08
0.11
1.4
1.3
—
—
—
0
0
107
1103
0.97
0.10
2.8
2.8
4.47
4.27
pmol/l
1.53
92
922
27
253
1.07
0.08
1.4
1.3
—
—
—
0
0
860
8659
0.99
0.08
3.4
3.7
8.06
9.71
mg/mmol
0.57
514
5416
309
3131
0.99
0.08
2.0
2.3
63.64
67.04
e9/l
1.11
240
2392
1195
12013
0.99
0.07
3.9
5.2
1.97
1.80
e9/l
0.64
1040
10292
1209
12153
0.99
0.07
3.8
5.2
0.19
0.20
e9/l
0.18
1032
10294
24
256
0.94
0.07
1.0
1.5
—
—
—
0
0
11
98
1.12
0.07
1.2
1.1
—
—
—
0
0
19
177
1.07
0.06
1.1
1.2
3.50
5.01
u/ml
—
6
89
17
159
1.07
0.05
2.2
2.2
46.00
65.03
ug/min
—
5
37
76
743
1.02
0.05
1.4
1.4
263.15
264.78
ug/g
0.03
43
456
55
565
0.97
0.04
1.7
1.6
—
—
—
0
0
12
111
1.08
0.04
1.0
1.5
—
—
—
0
0
12
111
1.08
0.04
1.0
1.5
—
—
—
0
0
12
112
1.07
0.03
1.2
1.1
—
—
—
0
0
22
229
0.96
0.02
1.1
1.0
—
—
—
0
0
1379
13816
1.00
0.02
4.9
7.9
4.55
4.47
e9/l
0.46
1176
11823
27
262
1.03
0.02
1.0
1.2
—
—
—
0
0
115
1141
1.01
0.01
2.3
2.0
11.51
10.70
nmol/l
0.38
97
950
12
114
1.05
0.00
1.0
1.5
—
—
—
0
0
15
144
1.04
0.00
1.1
1.4
—
—
—
0
0
15
144
1.04
0.00
1.1
1.4
—
—
—
0
0
23
224
1.03
0.00
1.5
1.2
—
—
—
0
0
25
244
1.02
0.00
1.4
1.2
—
—
—
0
0
39
396
0.98
0.00
1.6
1.6
4.71
4.10
mmol/24h
0.54
30
324
19
195
0.97
0.00
2.7
1.8
346.68
309.22
mu/l
0.23
19
176
20
205
0.98
0.00
1.5
1.3
—
—
—
0
0
24
245
0.98
0.00
1.0
1.5
—
—
—
0
0
43
425
1.01
0.00
1.5
1.5
2.68
4.46
iu/l
2.14
12
112
10
104
0.96
0.00
1.6
1.6
43.92
59.44
ug/l
—
10
98
11
114
0.96
0.00
1.1
1.0
—
—
—
0
0
15
152
0.99
0.00
1.1
1.1
—
—
—
0
0
45
448
1.00
0.00
1.2
1.9
62.22
58.69
%
0.47
45
448
66
662
1.00
0.00
1.3
1.2
0.19
1.06
u/ml
0.90
11
62
310
3102
1.00
0.00
4.4
4.0
—
—
—
0
0
66
657
1.00
0.00
1.3
1.6
18548.15
18389.62
e6/l
0.01
54
469
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
0.00
1.3
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.2
1.1
—
—
—
0
0
7
74
0.95
-0.00
1.3
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
11
110
1.00
-0.00
1.1
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
11
110
1.00
-0.00
1.1
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
18.69
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ADMED_ACHEI_GALANTAMINE – Use of galantamine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).